
+97142120555 Ext. 2610
dr.shahid@dmu.ae
Dr Shahid Ullah Khan joined Dubai Medical College for Girls as an Assistant Professor in Biochemistry in 2024. He earned his Ph. D degree in ‘Genome Wide Association Studies/Gastric Cancer from HZAU, Wuhan, P. R. China in 2019, and Postdoctoral in 2025 from SWU, P.R. China. He is recipient of several fellowships and awards such as: (i) World Top 2 % Scientist (ii) Young Scientist Award 2022, (iii) Asian Rank#01, Health and Biomedical Sciences (Biochemistry) Award ,2024, 2023, and 2022,(iii) World Scientists and University Ranking Award 2021 (iv) Agri Sciences China (Visiting Scientist-2020 at HZAU Wuhan, China, (v) Outstanding Research Awarded-2017 and 2019 ISO HZAU Wuhan China, (vi) OMG-2016 Award by HZAU Wuhan China, and (vii) Best Research Award-2022 by SCI-F (Biochemistry), around the globe. His current research activities are Genome Wide Association Studies, Nanotechnology and Natural Products etc. He has published over 100 research papers in peer reviewed international journals having 700+ IF, H-INDEX 38 and i10-76. He has also contributed Seven chapters in the book published by Springer. Dr. SK has attended many international and national conferences. He has more than 10 years of experience in teaching various undergraduate (UG), postgraduate (PG) and Doctoral (Ph.D.) courses. Dr. SK is a reviewer and editorial board member of various journals. Dr SK has passion for teaching and research.
Teaching & Service:
Patent
TRNANS-ANETHOLE ((E)-1-METHOXY-4-(1-PROPENYL) BENZENE), A NEW AND POTENT INHIBITOR OF PROLYL ENDOPEPTIDASE, Utility under 35 USC 111 (a). Patent Application Number: 17214886, filed March 2021. Muhammad Imran Khan, Depeng Wang, Najeeb Ullah, Fawad Ali Shah, Shah Fahad, Shahid Ullah Khan, Abdul Wahab, Arif Ullah Khan.
© DMU - Dubai, United Arab Emirates
